Recent Updates
Recently added Catalysts
CHRS Positive Sentiment Score: 70/100

Coherus Management to Participate in the 2024 Citi Global Healthcare Conference

Key Takeaway: Coherus BioSciences, Inc. has announced that its senior management will participate in the upcoming 2024 Citi Global Healthcare Conference. Dr. Theresa LaVallee, the Chief Development Officer, will be part of the panel discussing Novel Mechanisms in Oncology on December 3, 2024. This event will be webcasted for accessible viewing through the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Coherus management is engaged in a significant healthcare event.
  • Participation in the Citi Global Healthcare Conference enhances visibility.
  • Discussion on Novel Mechanisms in Oncology indicates innovation focus.

Full Press Release Details

REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that senior management will participate in the 2024 Citi Global Healthcare Conference, with Dr. Theresa LaVallee, Chief Development Officer, sitting on the Novel Mechanisms in Oncology Panel on December 3, 2024, at 3:15 p.m. ET.
The panel discussion will be accessible via webcast through a link on the Investor Events and Presentations section of the Coherus website: https://investors.coherus.com/events-presentations.
Coherus Contact Information:
VP, Investor Relations & Corporate Communications

Tags

Frequently Asked Questions

When will Coherus participate in the Citi Global Healthcare Conference?

Coherus will participate on December 3, 2024.

Who from Coherus will be on the oncology panel?

Dr. Theresa LaVallee will represent Coherus on the panel.

How can I access the panel discussion?

The panel can be accessed via webcast on Coherus's website.

What time is the oncology panel scheduled?

The panel is scheduled for 3:15 p.m. ET.

What is Coherus's stock symbol?

Coherus's stock symbol is NASDAQ: CHRS.

Last updated: Nov 27, 2024